SightC Capsule
Natural health product licensed in Canada
- Licence holder
- Sight Sage Foods and Nutrition Inc.
- NPN or DIN-HM
- 80096548
- Status
- Active licence
- Licence date
- 9 January 2020
- Revision date
- 10 July 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crataegus pinnatifida Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 mg | 20 mg | Not calculated |
| Rosa laevigata Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Lycium barbarum Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
| Ophiopogon japonicus Source : Tubercule Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 mg | 40 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Capsule ; maximum: 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Combination of Traditional Chinese Medicine Ingredients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, or if you are taking cardiac glycosides such as digitalis/digoxin, or blood pressure medication, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have gallstones, a bile duct obstruction, stomach ulcers or excess stomach acid. Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain. Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
Source
Official Health Canada record, licence 80096548
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.